HK1202128A1 - Channelrhodopsins for optical control of cells - Google Patents
Channelrhodopsins for optical control of cellsInfo
- Publication number
- HK1202128A1 HK1202128A1 HK15102671.5A HK15102671A HK1202128A1 HK 1202128 A1 HK1202128 A1 HK 1202128A1 HK 15102671 A HK15102671 A HK 15102671A HK 1202128 A1 HK1202128 A1 HK 1202128A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- channelrhodopsins
- cells
- optical control
- optical
- control
- Prior art date
Links
- 108010035848 Channelrhodopsins Proteins 0.000 title 1
- 230000003287 optical effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48728—Investigating individual cells, e.g. by patch clamp, voltage clamp
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559076P | 2011-11-12 | 2011-11-12 | |
| PCT/US2012/064665 WO2013071231A1 (en) | 2011-11-12 | 2012-11-12 | Channelrhodopsins for optical control of cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1202128A1 true HK1202128A1 (en) | 2015-09-18 |
Family
ID=47470101
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15102671.5A HK1202128A1 (en) | 2011-11-12 | 2015-03-16 | Channelrhodopsins for optical control of cells |
| HK18103122.5A HK1243717A1 (zh) | 2011-11-12 | 2018-03-05 | 用於細胞的光控的光敏感通道 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18103122.5A HK1243717A1 (zh) | 2011-11-12 | 2018-03-05 | 用於細胞的光控的光敏感通道 |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US10472398B2 (de) |
| EP (2) | EP2776455B1 (de) |
| KR (2) | KR102084803B1 (de) |
| DK (2) | DK2776455T3 (de) |
| ES (2) | ES2660114T3 (de) |
| HK (2) | HK1202128A1 (de) |
| PL (1) | PL2776455T3 (de) |
| WO (1) | WO2013071231A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9962558B2 (en) * | 2005-08-05 | 2018-05-08 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| US10022457B2 (en) * | 2005-08-05 | 2018-07-17 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| US20130309278A1 (en) * | 2005-08-05 | 2013-11-21 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| KR102084803B1 (ko) | 2011-11-12 | 2020-03-05 | 메사추세츠 인스티튜트 오브 테크놀로지 | 세포의 광학 조절을 위한 채널로돕신 |
| US10392426B2 (en) | 2014-02-07 | 2019-08-27 | Massachusetts Institute Of Technology | Blue-light-activated ion channel polypeptides and uses thereof |
| WO2015161308A1 (en) | 2014-04-18 | 2015-10-22 | Massachusetts Institute Of Technology | Mutant channelrhodopsins with altered ion selectivity |
| US10882892B2 (en) | 2014-08-05 | 2021-01-05 | Massachusetts Institute Of Technology | Channelrhodopsin variants and uses thereof |
| AU2017256910B2 (en) | 2016-04-29 | 2022-04-07 | Centre National De La Recherche Scientifique | Optogenetic visual restoration using Chrimson |
| US20190218256A1 (en) | 2016-06-03 | 2019-07-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Mutant light-inducible ion channel of channelrhodopsin |
| EP3464342A1 (de) | 2016-06-03 | 2019-04-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Mutante lichtinduzierbarer inonenkanal von chrimson |
| CN109716198B (zh) | 2016-06-17 | 2022-10-04 | 索邦大学 | 以可控的光强度照射物体的装置及相关方法 |
| WO2018017831A1 (en) * | 2016-07-21 | 2018-01-25 | Massachusetts Institute Of Technology | Dummy-fluorescent protein fusions and methods of use |
| IL265010B2 (en) * | 2016-08-29 | 2024-06-01 | Univ Wayne State | Identification of mutant canlopsin variants with enhanced photosensitivity and methods for their use |
| CN110267972A (zh) * | 2016-11-06 | 2019-09-20 | 纳秒示波器科技有限公司 | 由多特征视蛋白进行的用于视力恢复的光学调制以及其其他应用 |
| EP3422065A1 (de) | 2017-06-28 | 2019-01-02 | Gensight Biologics | Objektiv, kamera und system für optogenetik mit solch einem objektiv |
| TWI653037B (zh) | 2018-01-11 | 2019-03-11 | 友睦科技股份有限公司 | 可控溫的遠紅外線照射設備 |
| US11875545B2 (en) | 2018-01-11 | 2024-01-16 | Gensight Biologics | Method and device for processing asynchronous signals generated by an event-based light sensor |
| US11858969B2 (en) * | 2018-09-18 | 2024-01-02 | California Institute Of Technology | Engineered light-sensitive proteins |
| EP3693061A1 (de) | 2019-02-05 | 2020-08-12 | Gensight Biologics | Verfahren zur steuerung einer optogenetischen vorrichtung mittels filtrierung und zugehörige vorrichtungen |
| EP3693060A1 (de) | 2019-02-05 | 2020-08-12 | Gensight Biologics | Verfahren zur steuerung eines optogenetischen vorrichtung unter verwendung einer befehlsregel für die strahlungsleistung einer lichtquelle und zugehörige vorrichtungen |
| EP3733139A1 (de) | 2019-05-02 | 2020-11-04 | Gensight Biologics | Betrachtungsvorrichtung und verfahren zur projizierung eines lichtsignals |
| US11454402B1 (en) | 2021-12-01 | 2022-09-27 | Mcevoy William B | Tabletop cooking assembly |
| EP4223768A1 (de) | 2022-02-04 | 2023-08-09 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Neuer mutanter bacteriorhodopsin-like-channelrhodopsin-ionenkanal |
| WO2024015705A1 (en) * | 2022-07-09 | 2024-01-18 | Bionic Sight, Llc | An optogenetic gene therapy for treating blindness |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1322439C (en) | 1988-03-28 | 1993-09-28 | Junji Ohyama | Ion permeable membrane and ion transport method by utilizing said membrane |
| DE19747377A1 (de) | 1996-10-25 | 1998-05-28 | Fraunhofer Ges Forschung | Verfahren zur Vorbereitung der Erzeugung strukturierter Metallschichten mit Hilfe von Proteinen |
| AU2001282037A1 (en) | 2000-07-27 | 2002-02-13 | Mib Munich Innovative Biomaterials Gmbh | Proton-translocating retinal protein |
| DE10216005A1 (de) * | 2002-04-11 | 2003-10-30 | Max Planck Gesellschaft | Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle |
| US9274099B2 (en) | 2005-07-22 | 2016-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Screening test drugs to identify their effects on cell membrane voltage-gated ion channel |
| EP1919497B1 (de) | 2005-07-22 | 2020-02-12 | The Board of Trustees of the Leland Stanford Junior University | Lichtaktivierter kationenkanal und dessen verwendung |
| CA2685900A1 (en) * | 2006-05-04 | 2007-11-15 | Wayne State University | Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids |
| WO2008086470A1 (en) | 2007-01-10 | 2008-07-17 | The Board Of Trustees Of The Leland Stanford Junior University | System for optical stimulation of target cells |
| US8401609B2 (en) | 2007-02-14 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
| US20110165681A1 (en) | 2009-02-26 | 2011-07-07 | Massachusetts Institute Of Technology | Light-Activated Proton Pumps and Applications Thereof |
| US9138596B2 (en) * | 2007-08-22 | 2015-09-22 | Cardiac Pacemakers, Inc. | Optical depolarization of cardiac tissue |
| WO2009119782A1 (ja) * | 2008-03-24 | 2009-10-01 | 国立大学法人東北大学 | 改変された光受容体チャネル型ロドプシンタンパク質 |
| CA2721635A1 (en) * | 2008-04-18 | 2009-10-22 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Compositions comprising halorhodopsin |
| DE102008020152B4 (de) * | 2008-04-22 | 2012-04-05 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle |
| WO2009131837A2 (en) * | 2008-04-23 | 2009-10-29 | The Board Of Trustees Of The Leland Stanford Junior University. | Systems, methods and compositions for optical stimulation of target cells |
| US20100087006A1 (en) | 2008-09-18 | 2010-04-08 | TransAlgae Ltd | Use of fluorescent protein in cyanobacteria and algae for improving photosynthesis and preventing cell damage |
| NZ602416A (en) | 2008-11-14 | 2014-08-29 | Univ Leland Stanford Junior | Optically-based stimulation of target cells and modifications thereto |
| JP6276591B2 (ja) | 2010-11-05 | 2018-02-07 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 光活性化キメラオプシンおよびその使用方法 |
| JP6002140B2 (ja) * | 2010-11-05 | 2016-10-05 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 安定化階段関数オプシンタンパク質及びその使用方法 |
| US20120214188A1 (en) | 2010-11-12 | 2012-08-23 | Nathan Klapoetke | Light-activated ion channel molecules and uses thereof |
| US8957028B2 (en) | 2010-11-13 | 2015-02-17 | Massachusetts Institute Of Technology | Red-shifted opsin molecules and uses thereof |
| KR102084803B1 (ko) * | 2011-11-12 | 2020-03-05 | 메사추세츠 인스티튜트 오브 테크놀로지 | 세포의 광학 조절을 위한 채널로돕신 |
-
2012
- 2012-11-12 KR KR1020147015784A patent/KR102084803B1/ko active IP Right Grant
- 2012-11-12 EP EP12808926.5A patent/EP2776455B1/de active Active
- 2012-11-12 EP EP17165633.3A patent/EP3214094B1/de active Active
- 2012-11-12 ES ES12808926.5T patent/ES2660114T3/es active Active
- 2012-11-12 PL PL12808926T patent/PL2776455T3/pl unknown
- 2012-11-12 US US14/357,635 patent/US10472398B2/en active Active
- 2012-11-12 ES ES17165633T patent/ES2801679T3/es active Active
- 2012-11-12 WO PCT/US2012/064665 patent/WO2013071231A1/en active Application Filing
- 2012-11-12 DK DK12808926.5T patent/DK2776455T3/en active
- 2012-11-12 DK DK17165633.3T patent/DK3214094T3/da active
- 2012-11-12 KR KR1020207005571A patent/KR102194185B1/ko active IP Right Grant
-
2015
- 2015-03-16 HK HK15102671.5A patent/HK1202128A1/xx unknown
-
2016
- 2016-11-23 US US15/359,875 patent/US10472399B2/en active Active
-
2018
- 2018-03-05 HK HK18103122.5A patent/HK1243717A1/zh unknown
-
2019
- 2019-08-02 US US16/530,047 patent/US10717769B2/en active Active
- 2019-09-13 US US16/570,429 patent/US10711044B2/en active Active
-
2020
- 2020-05-28 US US16/885,457 patent/US11274128B2/en active Active
-
2022
- 2022-02-10 US US17/668,766 patent/US20220169684A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200291074A1 (en) | 2020-09-17 |
| HK1243717A1 (zh) | 2018-07-20 |
| US10717769B2 (en) | 2020-07-21 |
| KR102194185B1 (ko) | 2020-12-22 |
| DK2776455T3 (en) | 2018-02-26 |
| US10472399B2 (en) | 2019-11-12 |
| EP2776455A1 (de) | 2014-09-17 |
| US10711044B2 (en) | 2020-07-14 |
| KR20140091743A (ko) | 2014-07-22 |
| EP3214094A1 (de) | 2017-09-06 |
| US10472398B2 (en) | 2019-11-12 |
| PL2776455T3 (pl) | 2018-07-31 |
| US20170088590A1 (en) | 2017-03-30 |
| US20140324134A1 (en) | 2014-10-30 |
| WO2013071231A1 (en) | 2013-05-16 |
| EP2776455B1 (de) | 2018-01-10 |
| ES2660114T3 (es) | 2018-03-20 |
| DK3214094T3 (da) | 2020-07-13 |
| KR102084803B1 (ko) | 2020-03-05 |
| ES2801679T3 (es) | 2021-01-12 |
| US20190352347A1 (en) | 2019-11-21 |
| US20200031883A1 (en) | 2020-01-30 |
| KR20200024336A (ko) | 2020-03-06 |
| US11274128B2 (en) | 2022-03-15 |
| US20220169684A1 (en) | 2022-06-02 |
| EP3214094B1 (de) | 2020-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243717A1 (zh) | 用於細胞的光控的光敏感通道 | |
| EP2771455A4 (de) | Zelllinie zur produktion eines adenoassoziierten virus | |
| ZA201400678B (en) | Alpha-amylase variants | |
| EP2682469A4 (de) | Optisch gesteuertes genexpressionssystem | |
| EP2700869A4 (de) | Optische einheit | |
| GB201200835D0 (en) | Lenses | |
| SG10201601434RA (en) | Cell Culture System | |
| GB201118579D0 (en) | Control of ion populations | |
| EP3008748A4 (de) | Optische ionenelemente | |
| EP2725401A4 (de) | Optisches objektivsystem | |
| HK1209560A1 (en) | Mechanism for discovery of small cells | |
| EP2788811A4 (de) | Steuerung von lichtwellenfronten | |
| GB201110042D0 (en) | Growth of cells | |
| EP2719942A4 (de) | Optische einheit | |
| EP2709204A4 (de) | Sauerstoffzelle | |
| SG11201403280PA (en) | Bioreactor | |
| EP2725342A4 (de) | Zelle zur optischen analyse | |
| GB201410312D0 (en) | Photobioreactor | |
| EP2677525A4 (de) | Reaktor | |
| HK1202578A1 (en) | Expression cassette | |
| EP2788805A4 (de) | Optische verbindungen | |
| GB201217406D0 (en) | Optical cell | |
| HUE058968T2 (hu) | Sejtkultúra tenyésztésére szolgáló eszköz | |
| EP2768941A4 (de) | Fotobioreaktor | |
| EP2681005A4 (de) | Laserzeichnungssteuerung |